Bruehl, Germany

Martin Kolb


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Kolb - Innovator in Radiation Therapy Technology

Introduction

Martin Kolb is a notable inventor based in Bruehl, Germany. He has made significant contributions to the field of radiation therapy through his innovative designs and patents. His work focuses on improving the precision and efficiency of irradiation devices.

Latest Patents

Martin Kolb holds a patent for a multi-leaf collimator, which is a device designed to delimit high-energy beams in irradiation devices, particularly for conformational radiation therapy. The invention features a multi-leaf collimator that includes several opposing leaves, which can be adjusted into the beam path. This design allows for the contour of the beam path to be shaped according to the volume that requires irradiation. The innovation reduces the need for beam-absorbent material, as the leaves consist of an appropriate thickness of this material only in the regions that interact with the high-energy beam during positional adjustments.

Career Highlights

Martin Kolb is associated with Siemens Aktiengesellschaft, a leading company in technology and engineering. His work at Siemens has allowed him to develop cutting-edge solutions that enhance the capabilities of radiation therapy equipment. His patent reflects his commitment to advancing medical technology and improving patient outcomes.

Collaborations

Throughout his career, Martin Kolb has collaborated with talented professionals, including Steffen Seeber and Joerg Stein. These collaborations have contributed to the successful development and implementation of innovative technologies in the field of radiation therapy.

Conclusion

Martin Kolb's contributions to the field of radiation therapy through his innovative patent demonstrate his expertise and dedication to improving medical technology. His work continues to influence the industry and enhance treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…